Back

A novel composite inflammatory–metabolic index for longterm prognosis after TAVR: the modifying role of left ventricular ejection fraction

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Conduction disturbances, procedural strategies, and prognostic determinants after transcatheter aortic valve implantation Aortic Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Omar Ayyad

Kaplan Medical Center, Rehovot (Israel)

7 More presentations in this session

Presentation thumbnail
Impact of TAVR on pacemaker dependency in patients with pre-existing devices: predictors and one-year outcomes
Doctor O. Ayyad (Rehovot, IL)
Abstract
Presentation thumbnail
Left bundle branch block and risk for pacemaker implantation after TAVI: insights from the SwissTAVI Cohort Study
Doctor H. Pfister-Meyer (Lucerne, CH)
Abstract
Presentation thumbnail
High-flow nasal oxygen during transcatheter aortic valve implantation under sedation: one-year follow-up of the HIGH-OXY-TAVR randomised controlled trial
Doctor A. Manzano (Barcelona, ES)
Abstract
Presentation thumbnail
Comparative prognostic impact of paravalvular leak versus permanent pacemaker implantation after transcatheter aortic valve implantation without reduced ejection fraction patients
Doctor Y. Kirii (Tsu, JP)
Abstract
Presentation thumbnail
Impact of permanent pacemaker implantation after transcatheter aortic valve implantation: an updated systematic review with meta-analysis of reconstructed time-to-event data
Doctor F. Jordan (Basel, CH)
Abstract

Access the full session

Session thumbnail
Conduction disturbances, procedural strategies, and prognostic determinants after transcatheter aortic valve implantation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of LVEF in patients undergoing TAVI: a meta-analysis of 75,085 patients
13 December 2025
thumbnail
Congress Presentation
Change in remnant lipid-inflammatory index predicts long-term outcomes in AMI survivors with achieved LDL-C targets
21 March 2026
thumbnail
Congress Presentation
Cardiometabolic differences between patients with reduced and preserved ejection fraction: a proposal for phenotyping
22 May 2023
thumbnail
Congress Presentation
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources